Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 424 | 1,785 | 36 | 1,338 | 2,501 |
| TOTAL | $491 | $2,010 | $79 | $1,412 | $2,565 |
| Non-Current Assets | |||||
| PPE Net | 43 | 47 | 51 | 53 | 23 |
| Other Non-Current Assets | 60 | 60 | 60 | 60 | 60 |
| TOTAL | $103 | $107 | $111 | $114 | $83 |
| Total Assets | $595 | $2,117 | $190 | $1,526 | $2,649 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 870 | 825 | 697 | 487 | 182 |
| Accrued Expenses | 347 | 313 | 139 | 296 | 102 |
| TOTAL | $1,217 | $1,138 | $837 | $783 | $284 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 2,715 |
| TOTAL | $17 | $20 | $28 | $28 | $2,744 |
| Total Liabilities | $1,234 | $1,158 | $864 | $811 | $3,028 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,197 | 43,183 | 34,278 | 34,278 | 34,278 |
| Common Shares | 2 | 2 | 34 | 34 | 34 |
| Retained earnings | -17,846 | -15,844 | -13,215 | -11,483 | -8,410 |
| TOTAL | $-640 | $959 | $-674 | $715 | $-379 |
| Total Liabilities And Equity | $595 | $2,117 | $190 | $1,526 | $2,649 |